MA08.05 Brain Penetration of Lorlatinib and Cumulative Incidence Rates for CNS and Non CNS Progression From a Phase 1/2 Study

Journal of Thoracic Oncology - United States
doi 10.1016/j.jtho.2018.08.379
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

CNS Penetration of the Opioid Glycopeptide MMP-2200: A Microdialysis Study

Neuroscience Letters
Neuroscience
2012English

Journal Club: Randomized Phase III Study of Whole-Brain Radiotherapy for Primary CNS Lymphoma

Neurology
Neurology
2015English

Incidence of CNS Tumors in Appalachian Children

Journal of Neuro-Oncology
Cancer ResearchOncologyNeurology
2017English

Phase I Trial of Lapatinib in Children With Refractory CNS Malignancies: A Pediatric Brain Tumor Consortium Study

Journal of Clinical Oncology
Cancer ResearchMedicineOncology
2010English

Drugs Acting on Central Nervous System (CNS) Targets as Leads for Non-CNS Targets

F1000Research
GeneticsMolecular BiologyPharmacologyBiochemistryMicrobiology ImmunologyMedicineToxicologyPharmaceutics
2014English

Brain Endothelium as a Site for CNS-directed Enzyme Therapy

Science-Business eXchange
2009English

P1.01-74 MET Exon 14-Altered Lung Cancers: Central Nervous System (CNS) Metastases and Patterns of CNS Progression on MET Inhibition

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

O211 HIV and the Brain: Neuro-Inflammation Long-Term, CNS Control of HIV Replication, Brain Disease in Suppressed Patients and Differential Penetration of Drugs

Journal of the International AIDS Society
EnvironmentalPublic HealthInfectious DiseasesOccupational Health
2008English

Non CNS Pediatric Malignancies in Mosul

Annals of the College of Medicine, Mosul
2010English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy